NanoViricides, Inc. reported earnings results for the first quarter ended September 30, 2023. For the first quarter, the company reported net loss was USD 1.97 million compared to USD 1.57 million a year ago. Basic loss per share from continuing operations was USD 0.17 compared to USD 0.14 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.23 USD | +2.50% | +6.96% | +20.59% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.59% | 14.13M | |
-3.21% | 102B | |
+1.19% | 96.09B | |
+2.13% | 22.28B | |
-16.93% | 21.4B | |
-8.84% | 18.14B | |
-39.98% | 17.02B | |
-14.13% | 16.09B | |
+6.44% | 13.83B | |
+32.32% | 11.97B |
- Stock Market
- Equities
- NNVC Stock
- News NanoViricides, Inc.
- NanoViricides, Inc. Reports Earnings Results for the First Quarter Ended September 30, 2023